In the worst case scenario, the trading may be resumed next year. This is based on the history of ANS's trading suspension in the past (2017 and 2016)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025